Although RIPK2 expression positively correlated with that of pro-inflammatory cytokines in the colonic mucosa of patients with CD and UC, enhanced expression of NOD1 and NOD2 was not observed in IBD patients (Watanabe et al., 2019). This evidence concerns the gene RIPK2 and inflammatory bowel disease.